WebApr 15, 2024 · Established in 2017, NiKang Therapeutics™ is a clinical-stage biotech company dedicated to developing innovative small molecule drugs. Our research relies on disease biology insights and structure-based drug design with a current focus on HIF2α, CDK2 and KRAS.
WebIn just a few years, NiKang has become a clinical stage biotech company focused on discovering and developing a pipeline of small molecule medicines for difficult-to-drug oncology targets. Our target selection is driven by deep insights into disease biology and molecular pathway.
DA:93PA:17MOZ Rank:94
NiKang Therapeutics and Pfizer Enter Clinical Trial Collaboration …
WebNov 30, 2021 · NiKang Therapeutics is a clinical stage biotech company focused on discovering and developing innovative small molecule oncology medicines to help patients with unmet medical needs. Our target...
DA:61PA:41MOZ Rank:11
NiKang Therapeutics Announces Completion of $200 Million …
WebMay 26, 2021 · NiKang Therapeutics is a clinical stage biotech company focused on discovering and developing innovative small molecules oncology medicines to help patients with unmet medical needs. Our target...
WebIn animal models, NKT3447 has demonstrated sustained blockage of the CDK2 pathway, potent inhibition of tumor growth or regression. See AACR 2024 presentation. NKT3447 is currently in a Phase 1 first-in-human study of solid tumors.
DA:97PA:46MOZ Rank:40
NiKang Therapeutics Enters into Clinical Trial Collaboration and …
WebDec 8, 2023 · About NiKang Therapeutics. NiKang Therapeutics is a clinical stage biotech company focused on discovering and developing innovative small molecule oncology medicines to help patients with...
DA:50PA:47MOZ Rank:69
NiKang Therapeutics Doses First Patient in a Phase 1/1b Study of
WebApr 15, 2024 · NiKang Therapeutics Doses First Patient in a Phase 1/1b Study of NKT3447, an Oral, Selective Inhibitor of CDK2 Which Reduces Cyclin E Expression. Business Wire. Mon, Apr 15, 2024, 8:00 AM EDT 3...
WebAbout us. NiKang Therapeutics, Inc. is a privately-held biotech company focused on developing novel small molecule oncology drug discovery. Their mission is to discover and develop...
DA:15PA:98MOZ Rank:25
NiKang Therapeutics Presents the Discovery and Unique …
WebApr 5, 2024 · NiKang Therapeutics is a clinical stage biotech company focused on discovering and developing innovative small molecule oncology medicines to help patients with unmet medical needs. Our target...
DA:24PA:89MOZ Rank:3
NiKang Therapeutics Enters into Clinical Trial Collaboration and …
WebDec 8, 2023 · NiKang Therapeutics Enters into Clinical Trial Collaboration and Supply Agreement to Evaluate NKT2152 in Combination with Standard-of-Care in First-Line Advanced Hepatocellular Carcinoma....
